Group items tagged

PBR Staff Writer Published 27 March 2014 The European Commission (EC) has granted marketing authorization for GlaxoSmithKline's (GSK's) once-weekly diabetes treatment, Eperzan (albiglutide). The drug is indicated for the treatment of type 2 diabetes mellitus in adults, to improve glucose control as monotherapy, when diet and exercise alone do not provide adequate glycaemic control in patients for whom the use of metformin is considered inappropriate due to contraindications or intolerance.

GSK has received approval from FDA for its Tanzeum subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.

Metabolic syndrome is a term used for a group of risk factors that, if present together in a person, increase the risk of heart disease, stroke and diabetes. It is also known as Syndrome X or Insulin Resistance Syndrome.

Childhood diet lower in fat and higher in fiber content can decrease risk for chronic diseases such as diabetes and heart disease in adulthood, shows study.

Medindia provides an latest health information for consumers, doctors and patients with 120,000 plus health articles and 200,000 searchable database of doctors and hospitals.The content on the website is created and maintained by a team that includes doctors, medical researchers, web designers and programmers.

Leading and reliable source of health news updates round the clock every day with RSS feeds